The authors were able to ameliorate glucose intolerance by suppressing sRANKL in two independent mouse models hypothesizing that RANKL is a potent activator of NF- κB on hepatocytes promoting cytokine expression and hepatic insulin resistance [13]. Here, TNFSF11 is linked to Glucose intolerance.